An Elusive Case of Mycosis Fungoides: Case Report and Review of the Literature
We present a case of a 58-year-old man who presented with 5 years of cutaneous symptoms and several months of fevers and night sweats, ultimately diagnosed as MF. Owing to diffuse CD30 positivity, he was a candidate for brentuximab vedotin, an antibody-drug conjugate medication that selectively targets the CD30 antigen. This resulted in an excellent therapeutic response.
Source: Journal of General Internal Medicine - Category: Internal Medicine Source Type: research
More News: Cancer & Oncology | Cutaneous T cell lymphoma | Dermatitis | Dermatology | Eczema | Hodgkin's Disease | Internal Medicine | Lichen Planus | Lupus | Lymphoma | Mycosis Fungoides | Non-Hodgkin's Lymphoma | Psoriasis | Skin | T-cell Lymphoma | Toxic Shock Syndrome | Toxicology